With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
The following test-and-teach case is an educational activity modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and will then read evidence-based information that supports the most appropriate answer choice. Please note that these questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the case, there will be a short post-test assessment based on material covered in the activity.
Genetic findings that affect the course of diseases have been increasing geometrically. Cardiology is one of the specialties that has benefited from recent discoveries. David Danar, MD, Scientific Director, MedscapeCME, interviewed John P. Kane, MS, MD, PhD, about the role of genetics in determining the risk for and management of heart disease.
The treatment options for oral anticoagulation therapy are constantly evolving. Join our expert panel, Drs. Graham Turpie, Jessica L. Mega, Jeffrey Weitz, as they discuss the new data and clinical implications of new anticoagulant medications for patients with ACS
Join Drs Topol, Califf, Hollenberg and Levy has they list the latest cardiovascular clinical trials demonstrating a genetically targeted response to treatment.
In our first program Drs Gibbons, Holmes, and Simari discuss cell therapy and the latest trials in intervention. Our second program features Drs Gibbons, Ackerman, and Redfield discuss personalized genomics and heart failure.
ABC, it's as simple as 123. Join Drs Blumenthal and Blaha as they provide their feedback from a preventive cardiology point of view as to what happened at the AHA Annual Meeting 2008.
Underdiagnosed and undertreated, PAD is a growing health and economic burden in an increasingly aging population. Routine screening and effective management strategies can reduce long-term adverse outcomes. Join Drs Bhatt, Steg, Hirsch, and Hiatt as they discuss treatment guidelines for prevention and treatment of PAD.
Cardiovascular (CV) disease is the single leading cause of death in the United States. Multiple risk factors such as hypertension, diabetes, obesity, and dyslipidemia contribute to multiple pathophysiologic/neurohormonal processes that affect the development of CV disease. This program will review current and emerging approaches to CV risk management. CME Provider: The Academy for Healthcare Education, Inc. Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
